Skip to content

A study of the efficacy and safety of sterile wound liquid dressings for wound healing in extremities

A study of the efficacy and safety of sterile wound liquid dressings for wound healing in extremities

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094840
Enrollment
Unknown
Registered
2024-12-29
Start date
2022-12-09
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and soft tissue defects caused by surgical trauma such as minor wounds, abrasions, and cuts

Interventions

Study group:Sterile wound liquid dressings
Control group:Recombinant human epidermal growth factor

Sponsors

Hebei Chuangyue Biotechnology Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: a. Patients aged 18~60 years old who intend to undergo skin and soft tissue defects, gender is not limited; b. The area of the skin defect is not more than 5 cm^2; c. No infection or only slight infection of the wound (no fever or transient low-grade fever, white blood cell <= 12×10^9/L, no restrictive antibiotics); d. Patients and their families are aware of and agree to participate in this study.

Exclusion criteria

Exclusion criteria: (1) The patient has a history of skin diseases and drug allergies in the past; (2) Insufficiency of the patient's important organs (heart, liver, kidney, lung, brain) or abnormal coagulation function or bone marrow function; (3) There is a history of tumor and surgery in the defect area. (4) Those who have a history of allergies to drugs and foods; (5) History of mental illness and antipsychotic drugs used months ago; (6) Pregnant and breastfeeding; (7) Previous history of diabetes.

Design outcomes

Primary

MeasureTime frame
Total efficiency;Adverse effects (safety);

Secondary

MeasureTime frame
Wound healing time;Average cost of treatment;Visual analogue scale;The Patient and Observer Scar Assessment Scale;

Countries

China

Contacts

Public ContactWencui Li

Shenzhen Second People's Hospital

liwencui@email.szu.edu.cn+86 139 2375 0767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026